Andrew J Sauer MD ✓

@AndrewJSauer · Kansas City, MO · joined 11 Jun 2014

Cardiologist @MidAmericaHeart, building programs to implement therapies, advance discovery, and foster innovation for patients suffering from heart disease.

20 309Followers

2 170Following

20 122Posts total

106.2KViews on collected posts

Against accounts of the same size

6 posts from the last 90 days, next to the 10K–100K follower range. shown widely, but few of those viewers react.

Median views13 128this account3 808median for 10K–100K

Reach, %64.64%this account12.23%median for 10K–100K

Engagement, %0.57%this account1.37%median for 10K–100K

Metric	This account	Median for 10K–100K	Ratio
Median views per post	13 128	3 808	3.45×
Reach (views ÷ followers)	64.64%	12.23%	5.29×
Engagement rate	0.57%	1.37%	0.42×

Others in this range → Compare with another account → How these benchmarks are built →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

33.6K1 Sep

4.8K

5.4K

20.7K2 Sep

36.2K

5.5K

Last 6 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.62%1 Sep

0.35%

0.80%

0.79%2 Sep

0.48%

0.52%

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.37%.

What the audience does

Likes69.6%486 in total

Reposts12.8%89 in total

Replies7.4%52 in total

Quotes1.3%9 in total

Bookmarks8.9%62 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Latest posts

The argument for studies needing to be finerenone vs “active comparator” falls flat when the so-called active comparator has not been shown to be better than placebo in these populations. The argument makes more sense for ASI vs nsMRA than it does for nsMRA vs sMRA. 5.5K views · 21 likes · 6 reposts · 2 replies 02 Sep 2026 Spironolactone Outcomes RCTs in the Last 20y #TOPCAT (HFpEF) ❓❌ #SPIRITHF (HFpEF) ❓❌ #CLEAR (Post-MI) ❌ #BARACKD (CKD) ❌ #ALCHEMIST (ESKD) ❌ #ACHIEVE (ESKD) ❌ One day we will hopefully have a positive RCT to elevate eminence based medicine to evidence based medicine! 36.2K views · 132 likes · 32 reposts · 10 replies 02 Sep 2026 I’m sorry but how does @escardio give MRA (without differentiating sMRA from nsMRA) a Class I for HFpEF? Where is the evidence for steroidal MRA? And even if we base on nsMRA, we have one study (FINEARTS-HF) and we somehow end up with a Class I? Make it make sense. 20.7K views · 130 likes · 15 reposts · 14 replies 02 Sep 2026 EP keeps winning on RCT names. SINGLE-AF lol. Well played. 5.4K views · 38 likes · 1 reposts · 3 replies 01 Sep 2026 Some solid questions here to consider tbh 4.8K views · 12 likes · 2 reposts · 3 replies 01 Sep 2026 Conference RCT dumps sure are exciting, but here are some tough questions: [1] What are the ethics of embargoing every cardiology RCT for months leading up to the conference? (If this is life-saving information, shouldn't it be released ASAP?) [2] Do you think releasing all of 33.6K views · 153 likes · 33 reposts · 20 replies 01 Sep 2026 My top ten tips for graduating fellows and faculty entering and continuing “early career” as I am transitioning into “mid-career”. A thread: 0 views · 1.6K likes · 435 reposts · 95 replies 27 Jun 2021